A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00739648 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
322
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen